Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Feb 5;14(2):e239152.
doi: 10.1136/bcr-2020-239152.

Fever in a patient with osteomyelitis: the diagnosis could be serotonin syndrome

Affiliations
Case Reports

Fever in a patient with osteomyelitis: the diagnosis could be serotonin syndrome

Matthew Gould et al. BMJ Case Rep. .

Abstract

Awareness of rare differential diagnoses of common clinical presentations helps promote early detection and prompt management of serious conditions. A 54-year-old man, with an infected non-union following a high tibial osteotomy, presented with an acutely discharging abscess to his proximal tibia. He was generally unwell with a Staphylococcus aureus bacteraemia. The tibia was debrided, CERAMENT G used as dead space management and a spanning external fixator applied. Postoperatively, pregabalin and tapentadol were commenced in addition to amitriptyline and sertraline, which the patient was taking regularly. Overnight, the patient developed hyperthermia, inducible clonus, hyperreflexia, agitation, confusion and rigors. Prompt recognition of the possibility of serotonin syndrome resulted in early cessation of serotonergic medications and a positive outcome. From this case an important message is that fever in a patient taking serotonergic medications should prompt a screening neurological examination. Clinicians should also be wary when patients are commenced on multimodal analgesia, including tapentadol.

Keywords: adult intensive care; drug interactions; orthopaedic and trauma surgery; pain; unwanted effects / adverse reactions.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
The Hunter Serotonin Toxicity Criteria (adapted).
Figure 2
Figure 2
Patient’s vital signs leading up to intensive care unit admission. Pregabalin was started at a dose of 75 mg two times per day (BD) (blue arrow) and increased to 150 mg BD (second blue arrow). A single dose of tapentadol was given (green arrow).

References

    1. Foong A-L, Grindrod KA, Patel T. Demystifying serotonin syndrome (or serotonin toxicity). Can Fam Physician 2018;64. - PMC - PubMed
    1. Nguyen CT, Xie L, Alley S, et al. . Epidemiology and economic burden of serotonin syndrome with concomitant use of serotonergic agents. Prim Care Companion CNS Disord 2017;19 10.4088/PCC.17m02200 - DOI - PubMed
    1. Scotton WJ, Hill LJ, Williams AC, et al. . Serotonin syndrome: pathophysiology, clinical features, management, and potential future directions. Int J Tryptophan Res 2019;12:117864691987392. 10.1177/1178646919873925 - DOI - PMC - PubMed
    1. Dunkley EJC, Isbister GK, Sibbritt D, et al. . The Hunter serotonin toxicity criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM 2003;96:635–42. 10.1093/qjmed/hcg109 - DOI - PubMed
    1. Boyer EW, Shannon M. Current concepts: the serotonin syndrome. N Engl J Med 2005;352:1112–20. - PubMed

Publication types

LinkOut - more resources